<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Biallelic germline mutations in the MYH gene cause MYH-associated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> (MAP) disease, an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> form of inherited <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>People with MAP tend to develop attenuated <z:hpo ids='HP_0005227'>multiple adenomatous colon polyps</z:hpo> during their lifetime and will have an increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Contrary to <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e>, the number of <z:mpath ids='MPATH_270'>adenomas</z:mpath> is often lower in MAP (from 5 to 100), and even some patients have recently been reported with no identified <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>There have been many investigations into MAP that have been conducted in many different countries </plain></SENT>
<SENT sid="4" pm="."><plain>Currently there is limited data on MAP in Morocco, and it is reasonable to think, that the prevalence of this form of genetic predisposition is as high as other <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic diseases</z:e> found in countries with high rates of consanguinity </plain></SENT>
<SENT sid="5" pm="."><plain>The aim of this study is to examine the frequency of MYH mutations in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and/or attenuated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> in Moroccan patients </plain></SENT>
<SENT sid="6" pm="."><plain>PATIENTS AND METHODS: The study population consisted of 62 patients; 52 with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, three of them had attenuated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> (2 to 99 <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath>) </plain></SENT>
<SENT sid="7" pm="."><plain>10 other patients were referred to our department for <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> without <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We carried out DNA analysis in 62 patients to screen for the three recurrent mutations c.494A&gt;G (p.Tyr165Cys), c.1145G&gt;A (p.Gly382Asp) and c.1185_1186dup, p.Glu396GlyfsX43, whereas 40 subjects were screened for germline MYH mutations in the whole coding sequence of the MYH gene by direct DNA sequencing </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these 40 patients, except two, had <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> without <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: Three patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and attenuated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> carried biallelic mutations in the MUTYH gene one with the c.494 A&gt;G mutation, one with the c.1105delC mutation, one with the c.1145G&gt;A mutation </plain></SENT>
<SENT sid="11" pm="."><plain>One patient with 25 <z:mpath ids='MPATH_270'>adenomas</z:mpath> without <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> carried the c.1145G&gt;A mutation at a homozygote state and one patient with 3 <z:mpath ids='MPATH_491'>polyps</z:mpath> was heterozygote for the mutation c.1145G&gt;A </plain></SENT>
<SENT sid="12" pm="."><plain>No biallelic mutations of MYH gene were detected in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and in patients with small number (&lt;5) of <z:mpath ids='MPATH_491'>polyps</z:mpath> without <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: We report the first biallelic MYH mutations in four Moroccan patients with clinical criteria of MAP; three of them had <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with attenuated <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>No MYH mutations were found in colorectal patients without <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Despite the relatively small sample size of the current study, our findings suggest that the MAP is not a frequent cause of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in Morocco as we had expected, and the molecular analysis of MYH gene should be restricted to patients displaying the classical phenotype of MAP </plain></SENT>
</text></document>